Brief: FDA Grants Request From Kilpest India's Unit To Update Authorized Labeling Of A Covid Detection Kit
24/07/2020 20:32
July 24 (Reuters) - U.S. FDA -
* FDA, IN JULY 21 LETTER, SAYS REQUEST FROM A UNIT OF KILPEST INDIA LTD TO
UPDATE
AUTHORIZED LABELING OF TRUPCR SARS-COV-2 DETECTION KIT IS GRANTED
Source text: (https://www.fda.gov/media/140357/download)
Further company coverage: KILP.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 3B Blackbio DX
See all newsBrief: 3B Blackbio DX Gets Tax Order For Demand Of 44.6 Million Rupees
Brief: 3B Blackbio DX Gets Order Worth 13.7 Million Rupees
Brief: 3B Blackbio Dx Gets Export Order Worth $192,800
Brief: Kilpest India Says National Company Law Tribunal Approved Scheme Of Amalgamation Between 3B Blackbio Biotech India, Kilpest India
Brief: Kilpest India Final Dividend 2.5 Rupees Per Share